BRAF mutations are the most common genetic alterations in thyroid cancer (59.7%), while RET fusions are present in about 10%–20% of differentiated thyroid cancer (Romei et al., 2008; Network, 2014; Pozdeyev et al., 2018). The gene discussed is RET; the disease is thyroid cancer.